Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 Patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (58)
A method for estimating the probability of adverse drug reactions
1981 • 10,725 citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
1994 • 8,631 citations
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 • 6,926 citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 • 5,293 citations
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 • 5,229 citations
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 • 4,752 citations
Exercise Capacity and Mortality among Men Referred for Exercise Testing
2002 • 3,819 citations
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 • 3,347 citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
1994 • 2,615 citations
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 • 2,068 citations
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
2008 • 1,939 citations
Statin-Associated Myopathy
2003 • 1,447 citations
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
2005 • 1,216 citations
Exercise for the Treatment of Depression
2009 • 895 citations
Mitochondrial threshold effects
2003 • 750 citations
Statin Adverse Effects
2008 • 636 citations
Statin-Associated Myopathy with Normal Creatine Kinase Levels
2002 • 559 citations
Exercise Capacity and Body Composition as Predictors of Mortality Among Men With Diabetes
2004 • 473 citations
Influence of Exercise, Walking, Cycling, and Overall Nonexercise Physical Activity on Mortality in Chinese Women
2007 • 356 citations
Genetic risk factors associated with lipid‐lowering drug‐induced myopathies
2006 • 248 citations
Clinical Perspectives of Statin-Induced Rhabdomyolysis
2006 • 237 citations
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems
2004 • 215 citations
Reproducibility of pain measurement and pain perception
2002 • 206 citations
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
2007 • 201 citations
Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors
1997 • 199 citations
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 • 194 citations
Current and future treatment of hyperlipidemia: the role of statins
1998 • 192 citations
Lifetime Recreational Exercise Activity and Breast Cancer Risk Among Black Women and White Women
2005 • 188 citations
Learning from pain scales: patient perspective.
2003 • 172 citations
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin
2000 • 134 citations
Physician Response to Patient Reports of Adverse Drug Effects
2007 • 130 citations
Statin Safety: An Assessment Using an Administrative Claims Database
2006 • 129 citations
Muscular Side Effects of Statins
2002 • 128 citations
Isolated Mitochondrial Myopathy Associated With Muscle Coenzyme Q10 Deficiency
2005 • 125 citations
Effects of Exercise on Neurobehavioral Function in Community‐Dwelling Older People More Than 75 Years of Age
1996 • 125 citations
Exercise for Female Osteoporosis
1998 • 83 citations
Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome
2007 • 79 citations
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance
2004 • 77 citations
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias
1999 • 59 citations
The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes
2004 • 51 citations
Underappreciated Statin-Induced Myopathic Weakness Causes Disability
2005 • 49 citations
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy
2001 • 45 citations
Physical exercise reduces risk of breast cancer in Japanese women
2003 • 44 citations
Simvastatin and side effects.
1991 • 44 citations
Life-style Modification in Peripheral Arterial Disease
2004 • 39 citations
Patient reporting of adverse drug reactions: useful information for pain management?
2003 • 35 citations
Postmarketing surveillance: Accuracy of patient drug attribution judgments
1990 • 33 citations
Mitochondrial Defects of Brain and Muscle
1990 • 32 citations
Switching Statin Therapy Using a Pharmacist‐Managed Therapeutic Conversion Program versus Usual Care Conversion Among Indigent Patients
2008 • 30 citations
Oxidation Injury in Patients Receiving HMG-CoA Reductase Inhibitors
2002 • 28 citations
Efficacy and Safety of Cerivastatin, 0.2 mg and 0.4 mg, in Patients with Primary Hypercholesterolemia: a Multinational, Randomised, Double-blind Study
1999 • 25 citations
Treating patients with peripheral arterial disease and claudication
2003 • 23 citations
Patient Drug Attributions and Postmarketing Surveillance
1994 • 20 citations
Muscle side effects associated with simvastatin therapy
1990 • 17 citations
Postmarketing surveillance of adverse drug reactions: patient self-monitoring.
1992 • 14 citations
New approaches to postmarketing surveillance
1986 • 12 citations
[Joggers live longer. The Osterbro study].
2001 • 4 citations
Effects Of Statin Treatment And Supplemental Co Q10 On C2C12 Myotubes
2005 • 1 citations